Skip to content
Eye Icon

Bitte Lieferland und Währung prüfen (Weltkugel-Icon klicken). Wechsel dauert etwa 10 Sekunden.

AFEGA® UTHEVER® NMN – 500 capsules of 500 mg

SKU: UTHEVER-NMN-250-K
Regular price €475,00 (incl. €75,84 MwSt.)

Beim Checkout wird die für Ihr Land gültige MwSt. addiert.

Shipping calculated at checkout

Lieferzeit: 3-4 Tage

AFEGA® UTHEVER® NMN provides 500 mg per capsule in a container of 500 capsules and is a larger-pack option for those who want nicotinamide mononucleotide in capsule form from a clearly defined branded raw material source. This format combines a simple capsule routine with a supply that can be planned for the long term.

NMN is one of the best-known NAD+ precursors and is mainly discussed in connection with cellular energy metabolism and healthy aging. For many users, capsules are the most practical option for simple everyday use.

Product format

  • 500 capsules of 500 mg NMN each
  • Total amount: 250 g NMN
  • Purity: > 99 %
  • CAS: 1094-61-7

What UTHEVER® means here

UTHEVER® stands for a clearly defined raw material brand. This product is therefore particularly suitable for people who value both NMN itself and a consistent branded raw material source.

Storage

NMN is stable at room temperature and has a shelf life of at least 2 years. Store in a dry place, protected from light, and keep the container tightly closed.

Why choose the larger pack

The 500-count container is intended for users who want to make NMN a planned, long-term part of their routine. It provides a substantially larger supply than smaller packages and reduces the need to reorder.

Dosage

For dosage information, please refer to the related BLOG post by Dr. Peter Niehenke.

Who this product may suit

  • for people who prefer to use NMN in capsule form rather than as a powder
  • for users who value a clearly defined branded raw material source
  • for anyone who prefers clearly dosed 500 mg capsules in a larger pack

Further information

More detailed information about NMN and other substances can be found on the AFEGA Research Group operated Facebook page.

Back to top